知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

22 条记录 (耗时 0.026 秒)

    Use of polyaspartic acid amides as leather auxiliary products
    1.
    发明授权
    Use of polyaspartic acid amides as leather auxiliary products 失效
    使用聚天冬氨酸酰胺作为皮革辅助产品

    公开(公告)号：US5885474A

    公开(公告)日：1999-03-23

    申请号：US11241

    申请日：1998-01-28

    申请人： Jurgen Reiners ,  Manfred Schnee ,  Torsten Groth ,  Winfried Joentgen ,  Gerd Schmitz ,  Harro Traubel ,  Nikolaus Muller

    发明人： Jurgen Reiners ,  Manfred Schnee ,  Torsten Groth ,  Winfried Joentgen ,  Gerd Schmitz ,  Harro Traubel ,  Nikolaus Muller

    IPC分类号： C08G73/10 ,  C14C9/00

    CPC分类号： C08G73/1092 ,  C14C9/00 ,  Y10T428/4935

    摘要： Leather can be pretreated to obtain good body, soft feel, and excellent grain smoothness and solidity with products having a molecular weight of 700 to 30,000 and which are obtainable by reaction ofA. polysuccinimide having a molecular weight, determined as the number-average, of 500 to 10,000, withB. 5 to 90 mol % based on the succinimide units of polysuccinimide A, and/or secondary amine, the nitrogen substituents of which contain 1 to 60 carbon atoms and which can be unsubstituted or substituted, at least 2.5 mol % of the nitrogen substituents of the amine containing at least 12 carbon atoms,C. optionally, (i) derivatives of C.sub.1 -C.sub.18 -monocarboxylic acids, C.sub.2 -C.sub.10 -dicarboxylic acids, and/or (ii) monoisocyanates, diisocyanates epichlorohydrin (for reaction of amino and/or hydroxyl groups on the nitrogen substituents of the reaction product of A and B), andD. 95 to 10 mol % of ring-opening base in the presence of water.

    摘要翻译： PCT No.PCT / EP96 / 03241 Sec。 371日期1998年1月28日 102（e）1998年1月28日PCT PCT 1996年7月23日PCT公布。 公开号WO97 / 06279 日期1997年2月20日可以预处理具有分子量为700〜30,000的产品的良好的身体，柔软的手感和良好的颗粒光滑度和稳定性，并且可以通过将分子量为A的聚琥珀酰亚胺 数均分子量为500〜10000，B为5〜90摩尔％，基于琥珀酰亚胺单元的聚琥珀酰亚胺A，和/或仲胺，其氮取代基含有1〜60个碳原子，可以是未取代的或 至少2.5mol％含有至少12个碳原子的胺的氮取代基，C.任选地，（i）C 1 -C 18 - 一元羧酸的衍生物，C 2 -C 10 - 二羧酸和/或（ii） 单异氰酸酯，二异氰酸酯表氯醇（用于在A和B的反应产物的氮取代基上的氨基和/或羟基的反应）和D.95至10摩尔％的开环碱在水的存在下反应。

    Switching device for direct-current applications
    4.
    发明授权
    Switching device for direct-current applications 有权
    直流应用的开关装置

    公开(公告)号：US07915985B2

    公开(公告)日：2011-03-29

    申请号：US12271562

    申请日：2008-11-14

    申请人： Gerd Schmitz ,  Volker Lang ,  Wolfgang Kremers ,  Lothar Winzen

    发明人： Gerd Schmitz ,  Volker Lang ,  Wolfgang Kremers ,  Lothar Winzen

    IPC分类号： H01H9/30 ,  H01H9/02 ,  H01H13/04 ,  H01H9/44 ,  H01H33/18

    CPC分类号： H01H9/443 ,  H01H1/20 ,  H01H9/36

    摘要： A switching device for direct-current applications includes a housing having a first wall and a second wall, a plurality of receiving areas for respective mutually substantially parallel current paths disposed in the housing. Each of the current paths has a respective stationary switching contact element and a respective movable switching contact element, the movable switching element being actuatable into a closed position and into an open position so as to form a respective air break, the respective movable switching contact elements being actuatable simultaneously. The switching device includes a plurality of arc-quenching devices associated with the current paths and disposed next to each other, and at least one magnet. The at least one magnet is configured to generate a magnetic field so as to generate a deflection force on the arcs so as to deflect the respective arcs toward at least one of the respective arc-quenching devices.

    摘要翻译： 用于直流应用的开关装置包括具有第一壁和第二壁的壳体，用于设置在壳体中的各个相互基本平行的电流路径的多个接收区域。 每个电流路径具有相应的固定开关接触元件和相应的可移动开关触点元件，可移动开关元件可致动到关闭位置并进入打开位置以形成相应的空气断路，各个可移动开关触点元件 可同时启动。 切换装置包括与电流路径相关联并彼此相邻布置的多个灭弧装置和至少一个磁体。 所述至少一个磁体被配置为产生磁场，以便在所述电弧上产生偏转力，以便使各个弧朝着相应的灭弧装置中的至少一个偏转。

    Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
    5.
    发明申请
    Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy 审中-公开
    遗传多态性作为药物不良反应（adr）和药物功效的预测诊断

    公开(公告)号：US20060204962A1

    公开(公告)日：2006-09-14

    申请号：US10544049

    申请日：2004-01-31

    申请人： Udo Stropp ,  Stephan Schwers ,  Harald Kallabis ,  Gerd Schmitz

    发明人： Udo Stropp ,  Stephan Schwers ,  Harald Kallabis ,  Gerd Schmitz

    IPC分类号： C12Q1/68 ,  C07H21/04 ,  C12P21/06 ,  C07K14/47

    CPC分类号： C07K14/4702 ,  A61K38/00 ,  C07K14/7156 ,  C07K14/8132 ,  C12Q1/6876 ,  C12Q2600/156

    摘要： The invention provides diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy or whether the human subject is a high or low responder or a good a or bad metabolizer of statins. The invention provides further diagnostic methods and kits including antibodies determining whether a human subject is at risk for a cardiovascular disease. Still further the invention provides polymorphic sequences and other genes.

    摘要翻译： 本发明提供了包括寡核苷酸和/或多核苷酸或衍生物的诊断方法和试剂盒，包括确定人类受试者在他汀类药物治疗后是否有获得不良药物反应风险的抗体，还是人类受试者是高反应者还是低反应者 他汀类药物或代谢物。 本发明提供了进一步的诊断方法和试剂盒，包括确定人受试者是否处于心血管疾病风险的抗体。 本发明还提供了多态序列和其他基因。

    Pigment preparations
    6.
    发明授权
    Pigment preparations 失效
    颜料制剂

    公开(公告)号：US5959001A

    公开(公告)日：1999-09-28

    申请号：US859961

    申请日：1997-05-21

    申请人： Klaus Walz ,  Gerd Schmitz ,  Michael Kressner ,  Udo Herrmann ,  Josef Leitermann

    发明人： Klaus Walz ,  Gerd Schmitz ,  Michael Kressner ,  Udo Herrmann ,  Josef Leitermann

    IPC分类号： C08K3/04 ,  C08K5/00 ,  C09B67/20 ,  C09D5/00

    CPC分类号： C09B67/006 ,  C08K3/04 ,  C08K5/0041

    摘要： Pigment preparations comprising at leasta) 5 to 80% by weight, based on the preparation, of pigment,b) a paste-making agent which is liquid at 20.degree. C. under normal pressure,c) an amine and/or salt thereof with an average molecular weight, determined as the number-average, of M.sub.n .ltoreq.500 g/mol andd) a homo- and/or copolymer of ethylenically unsaturated monomers or comonomers having an average molecular weight, determined as the number-average, of M.sub.n =10,000-100,000,are suitable for pigmenting organic macromolecular material, in particular polyurethane foams.

    摘要翻译： 颜料制剂包含至少a）5-80重量％，基于制备的颜料，b）在常压下在20℃下液体的糊剂，c）其胺和/或其盐 平均分子量确定为+ E，ovs M + EE n = 500g / mol，d）具有平均分子量的烯属不饱和单体或共聚单体的均聚物和/或共聚物 确定为+ E，ovs M + EE n = 10,000-100,000的数均值，适用于着色有机高分子材料，特别是聚氨酯泡沫。

    Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy
    8.
    发明申请
    Genetic Polymorphisms As Predictive Diagnostics For Adverse Drug Reactions (ADR) And Drug Efficacy 审中-公开
    遗传多态性作为不良药物反应（ADR）和药物功效的预测诊断

    公开(公告)号：US20090208967A1

    公开(公告)日：2009-08-20

    申请号：US12424803

    申请日：2009-04-16

    申请人： Udo Stropp ,  Stephan Schwers ,  Harald Kallabis ,  Gerd Schmitz

    发明人： Udo Stropp ,  Stephan Schwers ,  Harald Kallabis ,  Gerd Schmitz

    IPC分类号： C12Q1/68

    CPC分类号： C07K14/4702 ,  A61K38/00 ,  C07K14/7156 ,  C07K14/8132 ,  C12Q1/6876 ,  C12Q2600/156

    摘要： The invention provides diagnostic methods and kits including oligo and/or polynucleotides or derivatives, including as well antibodies determining whether a human subject is at risk of getting adverse drug reaction after statin therapy or whether the human subject is a high or low responder or a good a or bad metabolizer of statins. The invention provides further diagnostic methods and kits including antibodies determining whether a human subject is at risk for a cardiovascular disease. Still further the invention provides polymorphic sequences and other genes.

    摘要翻译： 本发明提供了包括寡核苷酸和/或多核苷酸或衍生物的诊断方法和试剂盒，包括确定人类受试者在他汀类药物治疗后是否有获得不良药物反应风险的抗体，还是人类受试者是高反应者还是低反应者 他汀类药物或代谢物。 本发明提供了进一步的诊断方法和试剂盒，包括确定人受试者是否处于心血管疾病风险的抗体。 本发明还提供了多态序列和其他基因。

    Method for effecting an electronic drive control
    9.
    发明授权
    Method for effecting an electronic drive control 有权
    实现电子驱动控制的方法

    公开(公告)号：US06671157B1

    公开(公告)日：2003-12-30

    申请号：US10048047

    申请日：2002-01-24

    申请人： Wolfgang Meid ,  Wilhelm Melchert ,  Gerd Schmitz

    发明人： Wolfgang Meid ,  Wilhelm Melchert ,  Gerd Schmitz

    IPC分类号： H01H4700

    CPC分类号： H01H9/563

    摘要： The invention relates to a method for effecting an electronic drive control of a drive coil of a protection system using an electronic device which comprises a microcontroller. The aim of the invention is to increase the serviceable life of a protection system. To this end, the invention uses a randomly selected and constantly changing delay time (tx) that occurs after a time (t2, t3) at which the supply voltage is established on the electronic device.

    摘要翻译： 本发明涉及一种利用包括微控制器的电子装置对保护系统的驱动线圈进行电子驱动控制的方法。 本发明的目的是提高保护系统的使用寿命。 为此，本发明使用在电子设备上建立电源电压的时间（t2，t3）之后发生的随机选择且不断变化的延迟时间（tx）。

    Retractor apparatus for a weft-inserting projectile in a weaving machine
    10.
    发明授权
    Retractor apparatus for a weft-inserting projectile in a weaving machine 失效
    用于纬编机的纬纱插入式伸缩装置

    公开(公告)号：US4415010A

    公开(公告)日：1983-11-15

    申请号：US313175

    申请日：1981-10-20

    申请人： Gerd Schmitz

    发明人： Gerd Schmitz

    IPC分类号： D03D47/24 ,  D03D49/54

    CPC分类号： D03D47/24 ,  D03D49/54

    摘要： The projectile weaving machine is provided with a retractor apparatus at the braking device in which an elastically yielding and damping body is disposed to absorb impact forces and damp vibrations. The elastically yielding and damping body is located between the stop surface of the retractor and a fulcrum between the retractor and a lever for moving the retractor within the apparatus. In some embodiments, the body is positioned between two parts of the retractor while in other embodiments, the body may be disposed between the retractor and the moving means or may be incorporated in the retractor itself.

    摘要翻译： 抛丸编织机在制动装置处设有牵开器装置，其中设置弹性屈服​​和阻尼体以吸收冲击力并减轻振动。 弹性收缩和阻尼体位于牵开器的止动表面和牵开器与杠杆之间的支点之间，用于使牵开器在装置内移动。 在一些实施例中，主体定位在牵开器的两个部分之间，而在其他实施例中，主体可以设置在牵开器和移动装置之间，或者可以并入到牵开器本身中。